0001485003-16-000178.txt : 20160922 0001485003-16-000178.hdr.sgml : 20160922 20160922165822 ACCESSION NUMBER: 0001485003-16-000178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160920 FILED AS OF DATE: 20160922 DATE AS OF CHANGE: 20160922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeCillis Arthur CENTRAL INDEX KEY: 0001685148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 161898068 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 1ST ST. #400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_147457788976789.xml FORM 4 X0306 4 2016-09-20 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001685148 DeCillis Arthur C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer Stock Option 3.37 2016-09-20 4 A 0 100000 0 A 2026-09-19 Common Stock 100000.0 100000 D 25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option. /s/ Arthur P. DeCillis, M.D. 2016-09-22